New Minoxidil Response Test Identifies if Topical Minoxidil Will Work to Grow Hair

New Minoxidil Response Test Identifies if Topical Minoxidil Will Work to Grow Hair

stop hair loss

Breakthrough Hair Loss Know-how Exams Hair Follicles for Minoxidil Response with 95.9% Accuracy

NEWPORT BEACH, CA, USA, April 7, 2022 / — The hair loss market won’t ever be the identical. Daniel Alain, an e-commerce hair loss answer supplier, launches the Minoxidil Response Take a look at, the primary and solely patented and clinically-validated diagnostic take a look at that may report with 95.9% accuracy if somebody is a responder to topical Minoxidil – the one FDA-approved topical hair progress remedy for Androgenetic Alopecia – additionally known as genetic hair loss in women and men.

Unknown till now, you need an enzyme present (SULT1A1) to transform Minoxidil to its energetic kind to regrow hair for androgenetic alopecia – the worldwide main reason behind hair loss in each women and men. Should you lack the enzyme, Minoxidil (additionally commercially identified by model names comparable to Rogaine®, Hims, Hers, Retains*) won’t give you the results you want. Till now, the science was not accessible to check for the enzyme’s presence within the hair follicle. Enter Daniel Alain, a hair loss R&D powerhouse holding quite a few patents, who has privately funded over 10 million {dollars} in hair loss medical research since 2011. By meticulous analysis and persistence, Daniel Alain’s R&D workforce found the necessity for the SULT1A1 enzyme for hair regrowth success with topical Minoxidil.

“I’ve been within the enterprise for over 30, years and I’ve seen the frustration and emotional toll of dropping one’s hair,” shares Founder and CEO, Daniel Alain Hafid. “I’ve devoted my life to discovering options to hair loss. The Minoxidil Response Take a look at is the largest growth to hit the hair loss class as it is going to assist women and men instantly decide one of the best plan of action to deal with their hair loss – no have to waste time, cash or false hope on a remedy that biologically doesn’t give you the results you want.”

The Minoxidil Response Take a look at (MRT) for women or for men is an easy, non-invasive, at-home hair pluck take a look at. Samples are despatched to Daniel Alain’s CLIA-certified DA Labs and evaluated for the presence of the SULT1A1 enzyme utilizing a proprietary, patented technique. Outcomes are secured in a HIPPA-compliant server and reported again to the client of their private DA Labs account. From there, the client can work immediately with their healthcare supplier on the subsequent steps to deal with their hair loss.

“We’re set on a course to endlessly change the way in which we method and deal with genetic hair loss,” mentioned Hafid. “MRT is only one of many thrilling new diagnostic hair loss exams that might be made accessible to shoppers from Daniel Alain. All will supply discreetness and comfort, made to be used within the privateness of residence to assist achieve management over hair loss and search one of the best options based mostly on one’s genetics and private response mechanisms.”


Based in 2004, Daniel Alain is the world’s main hair loss and hair enhancement firm. With a concentrate on offering options to girls’s hair loss irrespective of the place she is within the journey, Daniel Alain is actively engaged in R&D of options for feminine hair loss, inclusive of the world’s most premium European 100% human hair wigs and hair toppers. 2022 marks the growth of Daniel Alain into the boys’s hair loss class with an prolonged portfolio of diagnostic exams to assist establish genetic hair loss and predict the response to FDA-approved hair loss therapies, Minoxidil and Finasteride.

*All product and firm names are logos or registered marks ® of their respective holders. Use of them doesn’t suggest any affiliation with or endorsement by them.

Sabrina Little
Daniel Alain
+1 949-706-9880
email us here
Go to us on social media:

Source link

hair loss cure

Leave a Reply

Your email address will not be published. Required fields are marked *